Pancreatic Cancer Research

ResearcherIndiana University HealthNo recent work listed

Jesse Gore

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5704-4579; OpenAlex author ID A5055597936. Sources: OpenAlex.

Their work

Papers
12 (first author 7, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2013: 1 paper · 2014: 4 papers · 2015: 3 papers · 2016: 4 papers

Papers 12

  1. MicroRNA Expression in a Readily Accessible Common Hepatic Artery Lymph Node Predicts Time to Pancreatic Cancer Recurrence Postresection. First author DOI 10.1007/s11605-016-3208-x↗
  2. Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.canlet.2015.11.047↗
  3. Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model. Co-author DOI 10.1016/j.canlet.2016.05.037↗
  4. Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes. First author DOI 10.18632/oncotarget.6345↗
  5. Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma. First author DOI 10.1038/cddis.2015.264↗
  6. Pathophysiological role of microRNA-29 in pancreatic cancer stroma. Co-author DOI 10.1038/srep11450↗
  7. TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis. Co-author DOI 10.18632/oncotarget.3233↗
  8. Pancreatic cancer stroma: friend or foe? Co-author DOI 10.1016/j.ccr.2014.05.026↗
  9. A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile. First author DOI 10.1038/ajg.2014.331↗
  10. microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions. First author DOI 10.1038/onc.2013.405↗
  11. Selective inhibition of pancreatic ductal adenocarcinoma cell growth by the mitotic MPS1 kinase inhibitor NMS-P715. Co-author DOI 10.1158/1535-7163.mct-13-0324↗
  12. Molecular imaging in pancreatic cancer--a roadmap for therapeutic decisions. First author DOI 10.1016/j.canlet.2013.08.008↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Murray Korc · 12 shared papers, 2013–2016 · strength 0.77
  2. Kelly E. Craven · 5 shared papers, 2015–2016 · strength 0.37
  3. Stuart Sherman · 2 shared papers, 2014–2015 · strength 0.10
  4. Gregory A. Coté · 2 shared papers, 2014–2015 · strength 0.10
  5. Lakshmi Reddy Palam · 1 shared paper, 2015 · strength 0.06
  6. Hai Salfity · 1 shared paper, 2016 · strength 0.06
  7. Michael Garrett House · 1 shared paper, 2016 · strength 0.06
  8. Christopher M. Schmidt · 1 shared paper, 2016 · strength 0.06
  9. Haoxu Ouyang · 1 shared paper, 2014 · strength 0.06
  10. Gabriela Krämer-Marek · 1 shared paper, 2013 · strength 0.06
  11. Jason J. Kwon · 1 shared paper, 2015 · strength 0.05
  12. Janaiah Kota · 1 shared paper, 2015 · strength 0.05
  13. Roger B. Slee · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.